We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Leica Microsystems' US Acquisition Expands Histopathology Range

By Labmedica staff writers
Posted on 19 May 2008
In a move that further advances its strong global position in the histopathology field, Leica Microsystems announced the acquisition of the assets of US-based Coretech Holdings. More...
The acquired concern is to become a business unit within Leica Microsystems' Biosystems Division, and will be renamed Leica Biosystems St. Louis, LLC. Terms of the transaction were not disclosed.

Composed of a group of strong brands including McCormick Scientific, The Vibratome Company, Paraplast embedding media, TurbOflow II histology cassettes and myNeuroLab.com, Coretech (St. Louis, MO, USA) provides an extensive range of systems, instruments, reagents, and consumables for the clinical and research histology laboratory.

According to Doug Martin, formerly CEO of Coretech Holdings and now Vice President & General Manager of Leica Biosystems St. Louis, LLC, The synergies created by combining the Coretech products and team with those of Leica Microsystems are considerable. Both companies will quickly leverage an improved product offering for our customers and expand our ability to service their needs.

Anne De Greef-Safft, President of Leica Microsystems' Biosystems Division added, With this acquisition, Leica Microsystems continues to broaden and strengthen the product line we offer our customers. The benefit to customers is that they now have a single partner to come to for all their histology equipment, reagent, and consumable needs. Having internal R&D, as well as manufacturing capabilities for the instrument and their associated reagents and consumables allows us to better optimize the entire system, leading to higher quality and more consistent results for our customers.

Leica Microsystems (Wetzlar, Germany) is a leading global developer and producer of precision optical systems for the analysis of microstructures. The company manufactures a broad range of products requiring microscopic imaging, measurement, and analysis, and offers system solutions for life sciences including biotechnology and medicine, R&D of raw materials, and industrial quality assurance. Leica Microsystems is represented in over 100 countries with 9 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers.


Related Links:
Coretech
Leica Microsystems

New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
PSA Assay
CanAg PSA EIA
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.